Aiping Xie

Title: Aiping Xie: Innovator in Pharmaceutical Chemistry

Introduction

Aiping Xie is a notable inventor based in Jinan, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. Her work has implications for the development of therapeutic agents.

Latest Patents

Aiping Xie holds a patent for a process for preparing and purifying bortezomib. This synthetic process involves converting racemic boronic esters into mixtures of diastereomers through a reaction with a suitably protected L-phenylalanine derivative. The process includes the removal of the protecting group and the selective isolation of the desired diastereomer, which is then converted into bortezomib or bortezomib anhydride. This innovation is crucial for the efficient production of bortezomib, a drug used in cancer treatment.

Career Highlights

Aiping Xie is associated with Scinopharm Taiwan, Ltd., where she continues to advance her research in pharmaceutical development. Her expertise in synthetic processes has positioned her as a valuable asset in the industry.

Collaborations

Aiping has collaborated with notable colleagues, including Julian Paul Henschke and Xin Huang. These partnerships have fostered a collaborative environment that enhances innovation in their research endeavors.

Conclusion

Aiping Xie's contributions to pharmaceutical chemistry, particularly through her patent on bortezomib synthesis, highlight her role as an influential inventor in the field. Her work continues to impact the development of important therapeutic agents.